Figure 2.
Longitudinal variation (n = 42) of Fabry biomarker levels in a 30-year-old untreated male (no ERT) (participant no. 1). For lyso-Gb3 analogues, the mass difference in Da compared to lyso-Gb3 is indicated in brackets.
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.